策略驱动实施：以色列的 COVID 疫苗接种。
Strategy drives implementation: COVID vaccination in Israel.
机构信息
Robert F. Wagner Graduate School of Public Service, New York University, New York, USA.
出版信息
Isr J Health Policy Res. 2021 Feb 1;10(1):9. doi: 10.1186/s13584-021-00445-1.
Abstract
This commentary on Rosen, Waitzberg, and Israeli's assessment of Israel's COVID response points to differences in the coherence of each national government's strategy as the key factor influencing the effectiveness of the vaccine drive. The strengths of the Israeli healthcare system facilitated implementation of the roll-out, but the government's unambiguous prioritization of vaccination drove implementation success.
摘要
这篇评论是对罗森、韦茨伯格和以色列人对以色列 COVID 应对措施的评估，指出了每个国家政府战略的一致性差异是影响疫苗接种运动效果的关键因素。以色列医疗体系的优势促进了疫苗的推出，但政府明确优先接种疫苗推动了实施的成功。
相似文献
1
Strategy drives implementation: COVID vaccination in Israel.策略驱动实施：以色列的 COVID 疫苗接种。
Isr J Health Policy Res. 2021 Feb 1;10(1):9. doi: 10.1186/s13584-021-00445-1.
2
Israel's rapid rollout of vaccinations for COVID-19.以色列为 COVID-19 推出的疫苗快速接种计划。
Isr J Health Policy Res. 2021 Jan 26;10(1):6. doi: 10.1186/s13584-021-00440-6.
3
Why Does Israel Lead the World in COVID-19 Vaccinations? Applying Mass Casualty Event Principles to COVID-19 Vaccination Programs.为什么以色列在 COVID-19 疫苗接种方面领先全球？将大规模伤亡事件原则应用于 COVID-19 疫苗接种计划。
Int J Environ Res Public Health. 2021 May 18;18(10):5362. doi: 10.3390/ijerph18105362.
4
Early Covid-19 vaccination rollout: a commentary from England.早期新冠肺炎疫苗接种推广：来自英格兰的评论。
Isr J Health Policy Res. 2021 Feb 26;10(1):18. doi: 10.1186/s13584-021-00451-3.
5
What can we learn from Israel's rapid roll out of COVID 19 vaccination?从以色列迅速推出 COVID-19 疫苗接种中学到了什么？
Isr J Health Policy Res. 2021 Jan 26;10(1):5. doi: 10.1186/s13584-021-00441-5.
6
Actionable lessons for the US COVID vaccine program.美国新冠疫苗计划的可操作经验教训。
Isr J Health Policy Res. 2021 Feb 19;10(1):14. doi: 10.1186/s13584-021-00452-2.
7
The rollout of the COVID-19 vaccination: what can Canada learn from Israel?新冠疫苗的推广：加拿大可以从以色列学到什么？
Isr J Health Policy Res. 2021 Feb 17;10(1):12. doi: 10.1186/s13584-021-00449-x.
8
Who should be vaccinated first? Comparing vaccine prioritization strategies in Israel and European countries using the Covid-19 Health System Response Monitor.谁应该优先接种疫苗？利用新冠疫情健康系统应对监测比较以色列和欧洲国家的疫苗优先接种策略。
Isr J Health Policy Res. 2021 Feb 19;10(1):16. doi: 10.1186/s13584-021-00453-1.
9
One size does not fit all: Lessons from Israel's Covid-19 vaccination drive and hesitancy.一刀切并不适用于所有人：以色列新冠疫苗接种运动及接种犹豫带来的教训。
Vaccine. 2021 Jul 5;39(30):4027-4028. doi: 10.1016/j.vaccine.2021.06.004. Epub 2021 Jun 5.
10
Drawing on Israel's Experience Organizing Volunteers to Operationalize Drive-Through Coronavirus Testing Centers.借鉴以色列组织志愿者运作免下车冠状病毒检测中心的经验。
Disaster Med Public Health Prep. 2020 Dec;14(6):812-814. doi: 10.1017/dmp.2020.104. Epub 2020 Apr 16.
引用本文的文献
1
A Scoping Review of Factors Affecting COVID-19 Vaccination Uptake and Deployment in Global Healthcare Systems.影响全球医疗系统中新冠疫苗接种率及推广因素的范围综述
Vaccines (Basel). 2024 Sep 25;12(10):1093. doi: 10.3390/vaccines12101093.
2
A Scalar Approach to Vaccination Ethics.疫苗接种伦理的标量方法。
J Ethics. 2024;28(1):145-169. doi: 10.1007/s10892-023-09445-6. Epub 2023 Sep 20.
3
Investigating the Marginal and Herd Effects of COVID-19 Vaccination for Reducing Case Fatality Rate: Evidence from the United States between March 2021 to January 2022.调查新冠疫苗接种在降低病死率方面的边际效应和群体效应：来自2021年3月至2022年1月美国的证据。
Vaccines (Basel). 2023 Jun 9;11(6):1078. doi: 10.3390/vaccines11061078.
4
The COVID-19 pandemic posed many dilemmas for policymakers, which sometimes resulted in unprecedented decision-making.新冠疫情大流行给政策制定者带来了许多困境，有时导致了前所未有的决策。
Isr J Health Policy Res. 2023 Apr 18;12(1):13. doi: 10.1186/s13584-023-00564-x.
5
Rapidly Establishing an Ultra-Cold Supply Chain of Vaccines in Israel: Evidence for the Efficacy of Inoculation to Mitigate the COVID-19 Pandemic.以色列迅速建立超低温疫苗供应链：接种疫苗减轻新冠疫情大流行效果的证据
Vaccines (Basel). 2023 Feb 3;11(2):349. doi: 10.3390/vaccines11020349.
6
Impact of societal resilience on vaccine hesitancy and uptake: Lessons learned from the Israeli experience.社会复原力对疫苗犹豫和接种率的影响：从以色列经验中汲取的教训。
Int J Disaster Risk Reduct. 2022 Sep;79:103181. doi: 10.1016/j.ijdrr.2022.103181. Epub 2022 Jul 19.
7
Determinants and Variations of COVID-19 Vaccine Uptake and Responses Among Minority Ethnic Groups in Amsterdam, the Netherlands.荷兰阿姆斯特丹少数族裔群体中新冠疫苗接种率及反应的决定因素和差异
Front Public Health. 2022 Feb 17;10:761987. doi: 10.3389/fpubh.2022.761987. eCollection 2022.
8
Sharing reflections and expressing appreciation upon completing a decade as co-editor of the IJHPR.在担任 IJHPR 联合编辑十年后，分享反思并表达感激之情。
Isr J Health Policy Res. 2021 Dec 15;10(1):63. doi: 10.1186/s13584-021-00497-3.
9
Towards efficacy and sustainability of global, regional and national COVID-19 vaccination programs.迈向全球、区域和国家新冠疫苗接种计划的有效性与可持续性。
J Glob Health. 2021 Sep 11;11:03099. doi: 10.7189/jogh.11.03099. eCollection 2021.
10
Addressing vaccine hesitancy and access barriers to achieve persistent progress in Israel's COVID-19 vaccination program.解决疫苗犹豫和获取障碍，以实现以色列 COVID-19 疫苗接种计划的持续进展。
Isr J Health Policy Res. 2021 Aug 2;10(1):43. doi: 10.1186/s13584-021-00481-x.
本文引用的文献
1
Israel's rapid rollout of vaccinations for COVID-19.以色列为 COVID-19 推出的疫苗快速接种计划。
Isr J Health Policy Res. 2021 Jan 26;10(1):6. doi: 10.1186/s13584-021-00440-6.
Zotero 插件